Research programme: CRH analogues - Neurobiological/University of CaliforniaAlternative Names: Corticotropin releasing hormone analogues research programme
Latest Information Update: 12 Dec 2003
At a glance
- Originator University of California at Berkeley
- Developer Neurobiological Technologies
- Mechanism of Action
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Cancer
Most Recent Events
- 31 Jul 2003 Discontinued - Preclinical for Cancer in USA (unspecified route)
- 17 Aug 2000 Preclinical development for Cancer in USA (Unknown route)